Navigation Links
Genetic aberration paves the way for new treatment of cancer disease
Date:11/6/2013

12-15 years of development and millions of dollars are typically the costs, when companies develop a new anti-cancer drug. Therefore all short cuts to a treatment are welcome. Researchers at Department of Veterinary Disease Biology, University of Copenhagen, recently discovered such a potential short cut.

"Our new research shows, that we might be able to introduce a treatment faster and cheaper than usual in the development of cancer treatment, and we estimate that it will be efficient in around 10 per cent of patients with colorectal cancer," says MD and PhD student Sune Nygrd, Department of Veterinary Disease Biology, University of Copenhagen.

Re-use of existing breast cancer treatment

In the new study the researchers have shown that around 10 per cent of colorectal cancer patients harbor an aberration in the gene called TOP2A in their cancer cells. These tumors could potentially benefit from treatment with a specific chemotherapeutic drug a so-called "anti-TOP2A treatment", which is already used in breast cancer patients with this gene aberration.

Clinical study begins

Approximately 600,000 patients die of colorectal cancer each year worldwide.

"If the first treatment doesn't cure a patient with colorectal cancer, the possibilities of additional treatment are limited," says Nils Brnner, MD, professor at University of Copenhagen.

"Therefore it is very important to find a new, efficient treatment," he adds.

The research group from the Department of Veterinary Disease Biology and professor Per Pfeiffer at Odense University Hospital have received funds from The Danish Cancer Society to initiate a clinical trial. Here it will be tested, if patients with the TOP2A gene defect could benefit from the targeted anti-TOP2A treatment.

"It is unique to go from a discovery in the laboratory towards a treatment for cancer patients at this pace. This is only possible when researchers and doctors work closely together," says Nils Brnner, University of Copenhagen.


'/>"/>

Contact: Nils Brünner
nbr@sund.ku.dk
45-26-14-47-08
University of Copenhagen
Source:Eurekalert

Related biology news :

1. Genetic study proves Israels wild boars originated in Europe
2. Dolphin genetic study provides revelations
3. Genetic rarity rules in wild guppy population, study finds
4. GenSeq: Updated nomenclature for genetic sequences to solve taxonomic determination issues
5. BUSM researchers study epigenetic mechanisms of tumor metastasis for improved cancer therapy
6. HIV -- Geneticists map human resistance to AIDS
7. Measuring segments of genetic material may help predict and monitor recurrence after thyroid cancer
8. Genetic variants associated with bronchodilator responsiveness
9. EUREKA grant to fund development of new optogenetic technique for mapping neural networks at UMMS
10. New software traces origins of genetic disorders 20 times more accurately
11. 2 genetic wrongs make a biochemical right
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... The research team of The Hong Kong ... identification by adopting ground breaking 3D fingerprint minutiae recovery and matching ... and accuracy for use in identification, crime investigation, immigration control, security ... ... A research team led by ...
(Date:3/24/2017)... Controller General of Immigration from Maldives Mr. Mohamed Anwar and ... international IAIR Award for the most innovative high security ePassport and eGates  ... ... Maldives Immigration Controller General, Mr. Mohamed Anwar ... right) have received the IAIR award for the "Most innovative high security ...
(Date:3/22/2017)... , March 21, 2017 ... Cloud used by retailers such as 1-800-Flowers and ... platform — Product Recommendations and Replenishment. Using Optimove,s machine ... more personalized product and replenishment recommendations to their ... also on predictions of customer intent drawn from ...
Breaking Biology News(10 mins):
(Date:4/26/2017)... ... 2017 , ... NextSteps 2017, NetDimensions’ annual global user conference, ... May on the following dates: , ?    London, UK from May 10-11, ?    New Orleans, ... Performance Institute will be the opening keynote speaker at the NextSteps EMEA ...
(Date:4/25/2017)... ... 2017 , ... As part of the Stago EdVantage Virtual University ... DIC in order to illuminate this clinical problem for people unfamiliar with the topic. ... in a high degree of morbidity and mortality. DIC is a confusing disorder from ...
(Date:4/25/2017)... Providence -based biotechnology ... technology to an undisclosed global pharmaceutical company, for ... Tregitopes, pronounced T·rej·itopes, are a set of peptides ... Annie De Groot and EpiVax CIO ... autoimmune disease therapy, Tregitopes are capable of engaging regulatory ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Leaders of ... of Quorum, will be featured in multiple sessions at this week’s Association of ... emerging trends to best practices in clinical research. , "We are excited to present ...
Breaking Biology Technology: